Dartmouth Health
Early Phase I Director, Oncologist
Dartmouth Health, , NH, United States
The Dartmouth Cancer Center (DCC) of Dartmouth Health and the Geisel School of Medicine at Dartmouth invite outstanding board-certified/board-eligible clinical trialists to apply for a faculty position as Director of Early Phase Clinical Trials at DCC.
We seek an enthusiasticand collaborative individual who will expand an already robust portfolio of early-phase cancer clinical trials, leveraging DCCs status as an NCI-designated Comprehensive Cancer Center, an NCI National Clinical Trials Network Lead Academic Participating Site, and a member of the Alliance, NRG and NCI CATCH-UP clinical trials consortia. A generous start-up package including 70% protected research time and access tostate-of-the-art pharmacology, biostatistics, and bioinformatics shared resources will be provided. In addition to full Membership in the DCC, a faculty appointment will be provided in either the Section of Medical Oncology or the Section of Hematology, at a rank commensurate with individual academic achievement.Clinical, Teaching, and Administrative Responsibilities (30%)Outpatient- Provide clinical excellence and coordination of care to oncology patients.
- Participate in subspecialty and interdisciplinary clinics.
- Actively participate in quality and patient safety improvement initiatives.
- Meet RVU benchmark per speciality as established by Dartmouth Cancer Center (DCC) and Dartmouth Health.
- Participate in coverage of the DCC inpatient oncology consult service, which is shared among oncology attending physicians.
- Communicate in an efficient manner with the hospitalists, radiologists, pathologists, and subspecialists in order to offer best clinical care.
- Teach medical, PA/NP students, and house staff at the Lebanon main campus.
- Participate in teaching activities within the hematology and oncology fellowship program.
- Participate in the Medical Oncology and Hematology sections and in institutional CME programs.
Administrative
- Attend and represent DCC in community events.
- The Physician will commit 70% of their time creating and expanding an active early phase clinical trial portfolio of investigator-initiated studies based on Dartmouth science, NCI network trials, and industry-sponsored studies.
- Provide leadership for the Early Phase Trials Program, collaborating with the Clinical Oncology Groups, and the DCC Research programs.
- Submit investigator-initiated trials for review and activation.
- Mentor junior investigators with the design and protocol development followed by submission of studies written by the junior investigators.
- Pursue intra-and extra-mural funding available to faculty as sources for research and program support.
- Recruit patients for clinical trials
- Completion of an approved fellowship program in oncology and/or hematology with board eligible/board certification in this specialty and experience in the clinical care of Hematology/Oncology patients.
- Significant knowledge of translational and clinical cancer research and its application to cancer drug development. Working knowledge of key areas of early drug development (biology, chemistry, pharmacology) and/ or experience in clinical drug development, specifically conducting early phase clinical trials.